Innova Captab IPO is a book built issue of Rs 570.00 crores. The issue comprises of fresh issue of Rs 320.00 crore and offer for sale of 0.56 crore shares.
Innova Captab IPO opens for subscription on December 21, 2023 and closes on December 26, 2023. The allotment for the Innova Captab IPO is expected to be finalized on Wednesday, December 27, 2023. Innova Captab IPO will list on BSE, NSE with tentative listing date fixed as Friday, December 29, 2023.
Innova Captab IPO price band is set at ₹426 to ₹448 per share. The minimum lot size for an application is 33 Shares. The minimum amount of investment required by retail investors is ₹14,784. The minimum lot size investment for sNII is 14 lots (462 shares), amounting to ₹206,976, and for bNII, it is 68 lots (2,244 shares), amounting to ₹1,005,312.
ICICI Securities Limited and Jm Financial Limited are the book running lead managers of the Innova Captab IPO, while Kfin Technologies Limited is the registrar for the issue.
| IPO Opening Date | December 21, 2023 |
|---|---|
| IPO Closing Date | December 26, 2023 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per share |
| IPO Price | ₹426 to ₹448 per share |
| Market Lot | 33 Shares |
| Min Order Quantity | 33 Shares |
| Listing At | BSE, NSE |
| Total Issue Size | [.] shares (aggregating up to ₹570.00 Cr) |
| Fresh Issue | [.] shares (aggregating up to ₹320.00 Cr) |
| Offer for Sale | 5,580,357 shares of ₹10 (aggregating up to ₹250.00 Cr) |
| Share holding pre issue | 50,082,072 |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Innova Captab IPO opens on December 21, 2023, and closes on December 26, 2023.
| Basis of Allotment Date | December 27, 2023 |
|---|---|
| Initiation of Refunds | December 28, 2023 |
| Credit of Shares to Demat Account | December 28, 2023 |
| IPO Listing Date | December 29, 2023 |
Investors can bid for a minimum of 33 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,784 |
| Retail (Max) | 13 | 429 | ₹192,192 |
| S-HNI (Min) | 14 | 462 | ₹206,976 |
| S-HNI (Max) | 67 | 2,211 | ₹990,528 |
| B-HNI (Min) | 68 | 2,244 | ₹1,005,312 |
Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three business segments. Firstly, it provides contract development and manufacturing services to Indian pharmaceutical companies. Secondly, the company has a domestic business dealing in branded generics. And thirdly, the company has an international business that deals in branded generics.
The company's product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments and liquid medicines. In the financial year 2023 and the three months ended June 30, 2023, the company produced and sold more than 600 different types of generics. These products were distributed under the company's own brands in the Indian market through a network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies. In addition, Innova Capitab exported its branded generic products to 20 and 16 countries in FY2023 and the three months ended June 30, 2023, respectively.
As of October 31, 2023, the company employed a team of 29 scientists and engineers in its research and development laboratory. The company's manufacturing facility is located in Buddi, Haryana
The company's customer base includes Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, Intas Pharmaceuticals Limited, Leeford Healthcare Limited, Medley Pharmaceuticals Limited, Cachet Pharmaceuticals Limited, Eris Healthcare Private Limited, Indoco Remedies Limited, J. B. Chemicals and Pharmaceuticals Limited, Oaknet Healthcare Private Limited, Zuventus Healthcare Limited, Ajanta Pharma Limited, Mankind Pharma Limited and Smart Laboratories Private Limited.
As of October 31, 2023, the company has 200 active product registrations and 20 registrations pending renewal with international authorities. In addition, 218 new registration applications are being processed with international authorities.
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
Innova Captab IPO is a main-board IPO of [.] equity shares of the face value of ₹10 aggregating up to ₹570.00 Crores. The issue is priced at ₹426 to ₹448 per share. The minimum order quantity is 33 Shares.
The IPO opens on December 21, 2023, and closes on December 26, 2023. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Innova Captab IPO opens on December 21, 2023 and closes on December 26, 2023.
Innova Captab IPO lot size is 33 Shares, and the minimum amount required is ₹14,784.
You can apply in Innova Captab IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services.
The finalization of Basis of Allotment for Innova Captab IPO will be done on Wednesday, December 27, 2023, and the allotted shares will be credited to your demat account by Thursday, December 28, 2023.
Check the IPO allotment status.
The Innova Captab IPO listing date is December 29, 2023.
To Bid online, you need
Demat Account and Pan card.
Login to SMC account and
select the Innova Captab IPO
Enter UPI Id & Mobile number
Place your number of bids
with the exchange
A UPI mandate is sent to your
UPI App to block your funds.